TLDR Higher caspase-1 levels found in balding scalps; reducing it may help treat hair loss.
The study found that caspase-1, a protein involved in inflammation, is expressed at higher levels in the scalp of individuals with androgenetic alopecia (AGA) compared to those without AGA. Finasteride treatment resulted in less expression of caspase-1. The findings suggest that endocrine-immune interactions play a crucial role in scalp tissue and that targeting caspase-1 may be a potential therapeutic approach for AGA.
466 citations,
June 2009 in “Experimental dermatology” We now understand more about what causes acne and this could lead to better, more personalized treatments.
52 citations,
June 2009 in “Current Opinion in Endocrinology, Diabetes and Obesity” The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.
21 citations,
January 2002 in “Journal of Cutaneous Medicine and Surgery” Finasteride affects hair growth by changing caspase and XIAP levels, potentially treating hair diseases.
27 citations,
July 2012 in “Dermatologic Surgery” Higher caspase-1 levels found in balding scalps; reducing it may help treat hair loss.
12 citations,
October 1999 in “Journal of The American Academy of Dermatology” 
65 citations,
October 1999 in “Journal of The American Academy of Dermatology” Finasteride effectively reduces hair loss by decreasing androgen levels.
581 citations,
October 1998 in “Journal of The American Academy of Dermatology” Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.
59 citations,
September 1994 in “The Journal of Clinical Endocrinology and Metabolism” Finasteride reduces scalp DHT levels, potentially treating male pattern baldness.
61 citations,
September 1994 in “The Journal of Clinical Endocrinology and Metabolism” 
30 citations,
August 1992 in “The Journal of Clinical Endocrinology and Metabolism” Finasteride doesn't affect hormone levels in normal men.
